The Library
Multivalent antimicrobial polymer nanoparticles target mycobacteria and gram-negative bacteria by distinct mechanisms
Tools
Tools
Tools
Richards, Sarah-Jane, Isulfi, Klea, Wilkins, Laura E., Lipecki, Julia, Fullam, Elizabeth and Gibson, Matthew I. (2017) Multivalent antimicrobial polymer nanoparticles target mycobacteria and gram-negative bacteria by distinct mechanisms. Biomacromolecules, 19 (1). pp. 256-264. doi:10.1021/acs.biomac.7b01561
|
PDF
WRAP-multivalent-antimicrobial-polymer-nanoparticles-target-mycobacteria-gram-negative-bacteria-Gibson-2018.pdf - Published Version - Requires a PDF viewer. Available under License Creative Commons Attribution 4.0. Download (3572Kb) | Preview |
|
![[img]](http://wrap.warwick.ac.uk/style/images/fileicons/application_pdf.png) |
PDF
WRAP-multivalent-antimicrobial-polymer-nanoparticles-mycobacteria-Gibson-2017.pdf - Accepted Version Embargoed item. Restricted access to Repository staff only - Requires a PDF viewer. Download (5Mb) |
Official URL: http://dx.doi.org/10.1021/acs.biomac.7b01561
Abstract
Due to the emergence of antimicrobial resistance to traditional small molecule drugs, cationic antimicrobial polymers are appealing targets. Mycobacterium tuberculosis is a particular problem, with multi- and total drug resistance spreading and more than a billion latent infections globally. This study reports nanoparticles bearing variable densities of poly(dimethylaminoethyl methacrylate) and the unexpected and distinct mechanisms of action this multivalent presentation imparts against Escherichia coli verses Mycobacterium smegmatis (model of M. tuberculosis), leading to killing or growth inhibition respectively. A convergent ‘grafting to’ synthetic strategy was used to assemble a 50-member nanoparticle library and using a high- throughput screen identified that only the smallest (2 nm) particles were stable in both saline and complex cell media. Compared to the linear polymers, the nanoparticles displayed 2- and 8-fold enhancements in antimicrobial activity against M. smegmatis and E. coli respectively. Mechanistic studies demonstrated that the antimicrobial particles were bactericidal against E. coli, due to rapid disruption of the cell membranes. Conversely, against M. smegmatis the particles did not lyse the cell membrane but rather had a bacteriostatic effect. These results demonstrate that to develop new polymeric anti-tuberculars the widely assumed, broad spectrum, membrane-disrupting mechanism of polycations must be re-evaluated. It is clear that synthetic nanomaterials can engage in more complex interactions with mycobacteria, which we hypothesise is due to the unique cell envelope at the surface of these bacteria.
| Item Type: | Journal Article | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Subjects: | T Technology > TP Chemical technology | |||||||||||||||||||||||||||
| Divisions: | Faculty of Science, Engineering and Medicine > Science > Chemistry Faculty of Science, Engineering and Medicine > Science > Life Sciences (2010- ) Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
|||||||||||||||||||||||||||
| Library of Congress Subject Headings (LCSH): | Antimicrobial polymers, Nanoparticles, Escherichia coli, Mycobacterium tuberculosis | |||||||||||||||||||||||||||
| Journal or Publication Title: | Biomacromolecules | |||||||||||||||||||||||||||
| Publisher: | American Chemical Society | |||||||||||||||||||||||||||
| ISSN: | 1525-7797 | |||||||||||||||||||||||||||
| Official Date: | 1 December 2017 | |||||||||||||||||||||||||||
| Dates: |
|
|||||||||||||||||||||||||||
| Volume: | 19 | |||||||||||||||||||||||||||
| Number: | 1 | |||||||||||||||||||||||||||
| Page Range: | pp. 256-264 | |||||||||||||||||||||||||||
| DOI: | 10.1021/acs.biomac.7b01561 | |||||||||||||||||||||||||||
| Status: | Peer Reviewed | |||||||||||||||||||||||||||
| Publication Status: | Published | |||||||||||||||||||||||||||
| Access rights to Published version: | Restricted or Subscription Access | |||||||||||||||||||||||||||
| RIOXX Funder/Project Grant: |
|
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
